CBRAIN (CBRAIN) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
21 Aug, 2026Executive summary
H1 2026 revenue grew 6% to DKK 140 million, driven by strong domestic sales, recurring software revenue, and AI-enabled product innovation.
Profitability remained high, with EBT up 16% to DKK 36 million and an EBT margin of 26%.
Strategic investments in AI and product innovation are central to growth, with AI now embedded across the F2 platform and notable progress in the U.S. and Europe.
International positioning strengthened by the first U.S. contract in California for AI-enabled environmental permitting.
Full-year guidance reiterated for 10%-15% revenue growth and 20%-25% EBT margin.
Financial highlights
H1 2026 revenue reached DKK 140 million, a 6% increase compared to H1 2025.
Software revenue rose 6% to DKK 107 million, representing 76% of total revenue.
Subscription revenue increased 8% to DKK 88 million, now 63% of total revenue.
EBITDA margin improved to 37% (up from 35%), and EBT margin reached 26% (up from 24%).
Profit for the period was DKK 28 million, up from DKK 24.1 million in H1 2025.
Outlook and guidance
Full-year 2026 guidance maintained: 10%-15% revenue growth and 20%-25% EBT margin.
H2 2026 revenue growth expected above 15% compared to H2 2025, supported by high visibility in Denmark and a growing international pipeline.
Optimism for continued momentum into 2027 and 2028, though no formal guidance issued for those years.
Increased customer activity and new AI products support a positive outlook.
Latest events from CBRAIN
- 2025 revenue fell 6%, but subscription and AI growth drive a strong 2026 outlook.CBRAIN
Q4 2025 - AI-driven standard software and international pilots drive renewed growth and 2026 optimism.CBRAIN
Q1 2026 - Subscription revenue up 24% and international business now one-third of total revenue.CBRAIN
Q3 2025 - Growth strategy pivots to global COTS niches, backed by strong financials and partnerships.CBRAIN
Q1 2025 - Revenue down 5%, but recurring revenue up 24% and global expansion continues.CBRAIN
Q2 2025 - 1H 2024 revenue up 6% to DKK 139m; global F2 expansion drives 2025 growth target.CBRAIN
Q3 2024 - H1 2024 revenue up 6% and EBT margin at 31%, driven by strong Danish growth and global expansion.CBRAIN
Q2 2024 - 2024 saw double-digit growth and global expansion, with a 32% EBT margin and strong outlook.CBRAIN
Q4 2024